Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKinsey
Federal Trade Commission
McKesson
Mallinckrodt
Dow
Chubb
Medtronic
Farmers Insurance

Generated: November 18, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Epelsiban

« Back to Dashboard

US Patents for Epelsiban

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Epelsiban ➤ Sign Up Piperazinediones as oxytocin receptor antagonists Glaxo Group Limited (Greenford, Middlesex, GB) ➤ Sign Up
Epelsiban ➤ Sign Up Compounds Glaxo Group Limited (Greenford, Middlesex, GB) ➤ Sign Up
Epelsiban ➤ Sign Up Compounds Glaxo Group Limited (Greenford, Middlesex, GB) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Julphar
Cipla
Argus Health
Accenture
Queensland Health
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.